CIK 0000064803 · Large accelerated filer
CVS HEALTH Corp
Sign in to watch- Ticker
- CVS
- Exchange
- NYSE
- Industry
- Retail-Drug Stores and Proprietary Stores
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 050494040
- Phone
- 4017651500
- Business address
- ONE CVS DR., WOONSOCKET, RI, 02895
- Former names
- CVS CAREMARK CORP, CVS/CAREMARK CORP, CVS CORP, MELVILLE CORP
- Open-market buys, last 90 days
- $2,001,315
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$2,001,315. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-03 | Lotvin Alan EVP&President-PharmacyServices | Option exercise | +70,398 | $58.34 | $4.1M | 179,581.37 |
| 2022-08-03 | Lotvin Alan EVP&President-PharmacyServices | Sale | −70,398 | $98.00 | $6.9M | 109,183.37 |
| 2022-08-03 | Lotvin Alan EVP&President-PharmacyServices | Option exercise | +50,501 | $54.19 | $2.7M | 159,684.37 |
| 2022-08-03 | Lotvin Alan EVP&President-PharmacyServices | Sale | −50,501 | $98.00 | $4.9M | 109,183.37 |
| 2022-08-03 | Lotvin Alan EVP&President-PharmacyServices | Option exercise · Stock Option | −70,398 | 70,399 | ||
| 2022-08-03 | Lotvin Alan EVP&President-PharmacyServices | Option exercise · Stock Option | −50,501 | 20,201 | ||
| 2022-08-03 | Finke Daniel P EVP/Pres, Health Care Benefits | Option exercise | +9,546 | $52.37 | $500K | 41,695.96 |
| 2022-08-03 | Finke Daniel P EVP/Pres, Health Care Benefits | Sale | −9,546 | $100.00 | $955K | 32,149.96 |
| 2022-08-03 | Finke Daniel P EVP/Pres, Health Care Benefits | Option exercise · Stock Option | −9,546 | 19,094 | ||
| 2022-06-28 | Moriarty Thomas M EVP & General Counsel | Option exercise | +49,279 | $58.35 | $2.9M | 675,552 |
| 2022-06-28 | Moriarty Thomas M EVP & General Counsel | Sale | −49,279 | $95.00 | $4.7M | 626,273 |
| 2022-06-28 | Moriarty Thomas M EVP & General Counsel | Option exercise | +50,502 | $54.19 | $2.7M | 676,775 |
| 2022-06-28 | Moriarty Thomas M EVP & General Counsel | Sale | −50,502 | $95.00 | $4.8M | 626,273 |
| 2022-06-28 | Moriarty Thomas M EVP & General Counsel | Option exercise | +38,873 | $74.30 | $2.9M | 665,146 |
| 2022-06-28 | Moriarty Thomas M EVP & General Counsel | Sale | −38,873 | $95.00 | $3.7M | 626,273 |
| 2022-06-28 | Moriarty Thomas M EVP & General Counsel | Option exercise · Stock Option | −49,279 | 98,558 | ||
| 2022-06-28 | Moriarty Thomas M EVP & General Counsel | Option exercise · Stock Option | −50,502 | 50,502 | ||
| 2022-06-28 | Moriarty Thomas M EVP & General Counsel | Option exercise · Stock Option | −38,873 | 116,622 | ||
| 2022-05-31 | Chaguturu Sreekanth K EVP and Chief Medical Officer | Grant or award | +0 | 0 | ||
| 2022-05-31 | Shah Prem S EVP and Co-President of Retail | Grant or award | +0 | 0 |
Page 16 of 24 · 466 trades